Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
nano-technology
Antiviral company Kastus completes Series A €5.65M funding
By
Sara Mageit
|
05:44 am |
June 22, 2021
The investment will go towards developing Kastus' patented light-powered anti-viral surface protection technology.